Investigation of the role of gut microbiota in cancer immunotherapy. Effectiveness of cancer therapy was assessed after various antibiotic treatments and post several antibiotic recovery time-points.
Metagenomic analysis of C57BL6 moue gut microbiome at day 0 and day 7 post injection of monomeric alpha-synuclein and alpha-synuclein fibrils in the striatum.
